Avoiding viral contamination in biotechnological and pharmaceutical processes

Nature Biotechnology

Volumn 16, Issue 11, 1998, Pages 1077-1079

  Henzler, Hans Jürgen ^a   Kaiser, Klaus ^a  

^a BAYER AG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ALBUMIN; AMINO ACID; ANTIBODY; ANTIOXIDANT; APROTININ; CITRATE SODIUM; GLYCINE; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; PROTEIN; RUTOSIDE; STABILIZING AGENT; SUCROSE; TRYPSIN; VIRUS ANTIGEN;

BIOTECHNOLOGY; CLEARANCE; DRUG CONTAMINATION; GAMMA RADIATION; HEATING; IMMUNOAFFINITY CHROMATOGRAPHY; ION EXCHANGE CHROMATOGRAPHY; PHARMACEUTICS; PRIORITY JOURNAL; PURIFICATION; SHORT SURVEY; ULTRAVIOLET RADIATION; VALIDATION PROCESS; VIRUS; VIRUS INACTIVATION;

EID: 0031738447     PISSN: 10870156     EISSN: None     Source Type: Journal    
DOI: 10.1038/3538     Document Type: Short Survey

References (9)

1. Maerz, H. et al. 1996. Nat. Biotechnol. 14:651-652.
2. Andersson, I. et al. 1996. 24th Conference of the International Society of Blood Transfusion in Makuhari, Japan.
3. Chin, S. et al. 1997. Photochem. Photobiol. 65:432-435.
4. Marx, G. et al. 1996. Photochem. Photobiol. 63:541-546.
5. Hiemstra, H. et al. 1991. Transfusion 31:32-39.
6. Spearman, C. 1908. Br. J. Psychol. 2:227-242.
7. Kaerber, G. 1931. Arch. Exp. Pathol. Pharmakol. 162:480-483.
8. Goelker, C.F. et al. 1996. Biologicals 24:103-111.
9. Huebner, G.E. et al. 1996. Arzneim.-Forsch./Drug Res. 46:657-661.